Navigation Links
Phase II study shows new cancer drug combination significantly delays breast cancer progression
Date:9/24/2011

Stockholm, Sweden: The first randomised trial to investigate the use of trastuzumab emtansine (T-DM1) an antibody-guided drug for the initial treatment of HER2- (human epidermal growth factor receptor-2) positive metastatic breast cancer has shown that it makes a significant difference to the time women live without their disease worsening.

Dr Sara Hurvitz, one of the trial investigators, will tell the 2011 European Multidisciplinary Cancer Congress [1] in Stockholm today (Sunday 25 September): "Our results showed that patients with metastatic breast cancer who received T-DM1 had a 41% improvement in the time they lived without their breast cancer worsening compared to those who received standard docetaxel chemotherapy plus trastuzumab. These provocative Phase II data illustrate that first-line treatment with T-DM1 provides a longer time for patients to live without cancer progression and with fewer side effects than standard chemotherapy plus trastuzumab."

Trastuzumab emtansine (T-DM1) is a novel type of cancer therapy known as an antibody drug conjugate (ADC). It combines the monoclonal antibody, trastuzumab, with a potent cytotoxic agent DM1 [2] through a stable linker and uses the HER2 targeting properties of trastuzumab to deliver the cell-killing agent DM1 into the cancer cells.

Dr Hurvitz, Director of the Breast Oncology Program for the Division of Hematology/ Oncology at The University of California, Los Angeles (UCLA), USA, will say that "T-DM1 is unique because it retains the cancer fighting properties of trastuzumab and delivers the DM1 agent directly to the tumour cell for destruction, while limiting exposure of the free DM1 drug to normal cells. This explains why patients who received T-DM1 had fewer side effects compared to those assigned to the chemotherapy-containing control arm in this study."

T-DM1 is specifically designed to attach trastuzumab to DM1 using a stable linker. The bound DM1 has little toxicit
'/>"/>

Contact: Kay Roche
kayroche@gmail.com
ECCO-the European CanCer Organisation
Source:Eurekalert

Page: 1 2 3

Related medicine news :

1. Medical Imaging Northwest Completes Phase I of Its Healthcare IT Integration to Maintain Patient Care Improvements
2. New High Purity Immunoglobulin Enters Phase III in Europe and the US
3. Poniard Pharmaceuticals Presents Positive Survival Data from a Phase 2 Clinical Study of Picoplatin in Metastatic Prostate Cancer at the 2010 American Society of Clinical Oncology Genitourinary Cancers Symposium
4. Nuvo Research enrolls first patient in Phase 2 WF10 allergic rhinitis trial
5. Askthedoctor.com Makes Medical Information More Accessible to the Public by Completing Phase 1 of US Expansion
6. Intellicate Announces New “Phased Return to Work” (PRtW) Service
7. Southampton scientists begin Phase II patient trial for new asthma treatment
8. Pilot Testing Phase Ends; Expansion Of Sales Force Begins
9. New phase II study supports potential of gs-9450 as new treatment option for steatohepatitis
10. Phase II study of an oral therapy for Gaucher disease yields positive results
11. Accumed Research Associates Expands Capabilities In Phase I and Bioequivalence Clinical Trials
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/13/2014)... According to the Kidney Disease Solution book review recently updated ... what to do to eliminate the root cause of ... review that readers can easily learn what foods to avoid ... Vkool also informs in its Kidney Disease Solution review that ... naturally. The book consists of a collection of natural remedies ...
(Date:7/13/2014)... Celebrity fitness trainer and former World Super ... with Aqua Health Labs for their flagship product PhytOriginal, ... The collaboration was recently announced live on ESPN Radio. ... actor, model, and a two time World Super Middleweight ... has prepared stars including Demi Moore, Hilary Swank and ...
(Date:7/13/2014)... July 13, 2014 If Dr. Lawrence Power ... has just launched at http://www.HealthYourself101.com will expand people’s ... , Power has set out to provide a health ... that’s actually – dare we say it? – entertaining to ... Power, “aims to engage the remote learner – the solitary ...
(Date:7/13/2014)... Recently, iFitDress.com, one of the most popular suppliers ... added a new selection of beautiful evening dresses ... a promotion for these evening gowns. Now, everybody can ... providing thousands of graceful gowns in its online store. ... France, Italy and many other countries. They are highly ...
(Date:7/12/2014)... (PRWEB) July 13, 2014 Recently, iFitDress.com, one ... new selection of red evening gowns . What’s more, ... to 56% off. , The company’s senior spokesman states, “We ... shopping on our website is an enjoyable shopping experience. In ... In our online store, low prices do not always mean ...
Breaking Medicine News(10 mins):Health News:Kidney Disease Solution Book Review Exposes Duncan Capicchiano's Newly Updated Kidney Disease Treatment Plan – Vkool.com 2Health News:Kidney Disease Solution Book Review Exposes Duncan Capicchiano's Newly Updated Kidney Disease Treatment Plan – Vkool.com 3Health News:Celebrity Fitness Expert Supports Revolutionary New Health Supplement 2Health News:Retired Ann Arbor Physician and Professor Wields New Media to Teach Health Science 2Health News:Retired Ann Arbor Physician and Professor Wields New Media to Teach Health Science 3Health News:Retired Ann Arbor Physician and Professor Wields New Media to Teach Health Science 4Health News:New and Beautiful Evening Dresses Unveiled by iFitDress.com 2Health News:Discounted Red Evening Gown Announced by iFitDress.com 2
... a hospitalization, patients are seen by a variety ... has primary responsibility for their care. However, faulty ... or other problems may keep the specialists, recommendations ... study by Martin Were, M.D., of the Regenstrief ...
... Ltd. will be unveiling a new diagnostic ultrasound system ... to be held from March 6th, 2009 in Vienna, ... with higher cost-effectiveness, flexibility, ease of use, and functionality. ... with the latest digital technologies engineered into a compact ...
... Legislation Report Card Ranks State Efforts: Finally, More "A,s" ... time, more U.S. states have received A grades than ... the 2009 Colorectal Cancer Legislation Report Card. Issued ... groups and medical professional societies, the report card was ...
... AP LIS to Interface with BioImagene,s Virtuoso(TM) ... 6 Impac Software, part of the ... solutions for anatomic pathology (AP) laboratories, and ... today announced the development of an interface ...
... headsets contaminated with bacteria that could infect patients ... new culprit has emerged in the spread of ... hospitals -- mobile phone headsets. , Turkish researchers ... in hospitals found that 95 percent were contaminated ...
... Valeant Pharmaceuticals (NYSE: VRX ) today announced that ... 12, 2009 at 9:00 a.m. Eastern Time, at the Hilton ... New Jersey 07078. The record date for stockholders entitled ... About Valeant , Valeant Pharmaceuticals International (NYSE: VRX ...
Cached Medicine News:Health News:Giving doctors the complete picture 2Health News:ALOKA Showcases a New Diagnostic Ultrasound System ProSound 4 at ECR 2009 in Vienna, Austria 2Health News:New Data Reveals That Gaps in Coverage for Those With Private Insurance Are Major Barriers to Colorectal Cancer Screening 2Health News:New Data Reveals That Gaps in Coverage for Those With Private Insurance Are Major Barriers to Colorectal Cancer Screening 3Health News:New Data Reveals That Gaps in Coverage for Those With Private Insurance Are Major Barriers to Colorectal Cancer Screening 4Health News:New Data Reveals That Gaps in Coverage for Those With Private Insurance Are Major Barriers to Colorectal Cancer Screening 5Health News:New Data Reveals That Gaps in Coverage for Those With Private Insurance Are Major Barriers to Colorectal Cancer Screening 6Health News:Impac Software and BioImagene Develop Workflow Solution for Digital Pathology and the Laboratory Information Systems 2Health News:Impac Software and BioImagene Develop Workflow Solution for Digital Pathology and the Laboratory Information Systems 3
(Date:7/11/2014)... -- Neurelis, Inc. ("Neurelis") today announced an agreement with ... by Biotie to purchase Neurelis, clearing the way for ... for pediatric and adult epilepsy patients who experience acute ... has advanced the development program for NRL-1 and worked ... required for NDA submission to the FDA.  Given the ...
(Date:7/10/2014)... CARLSBAD, Calif. , July 10, 2014 /PRNewswire/ ... products and services, has launched the FreeRunner™ knee ... runners, who suffer from patella mal-tracking return to ... anatomy differently than other braces, providing support when ... move normally when they don,t. Patellofemoral ...
(Date:7/10/2014)... JORDAN, Utah , July 10, 2014  BC ... solutions, and MiE America , Inc., a leading ... have entered into a long-term agreement naming BC Technical ... the US. MiE and BC Technical ... strategic agreement to establish BC Technical as the service ...
Breaking Medicine Technology:Neurelis Regains Rights to Intranasal Diazepam Program 2Neurelis Regains Rights to Intranasal Diazepam Program 3Breg Introduces Knee Brace to Help Runners with Patellofemoral Pain Syndrome 2BC Technical Partners With MiE America To Be Authorized Provider Of Systems & Service 2
... Inc. today announced that it has been awarded a ... $600,000 from the National Institute of Allergy and Infectious ...  The grant will be used to demonstrate the feasibility ... platelet recovery and improve survival in a mouse model ...
... TOPEX, Inc. announces the sale of its skin cancer ... energy SRT 100 superficial radiotherapy treatment system. Since TOPEX ... operating worldwide at hospital radiation oncology centers, dermatology and ... The low energy superficial radiotherapy system provides patients an ...
Cached Medicine Technology:Bolder BioTechnology Announces $600,000 Grant from NIH to Study Long-Acting IL-11 Analog in Treating Acute Radiation Syndrome 2TOPEX Sells Skin Cancer Business Operations to SENSUS Healthcare 2
Auto Suture MULTIFIRE PREMIUM skin stapler Disposable Loading Unit is a single use premium multi fire DLU that is available in four sizes....
... Appose Single Use Skin Staple Remover ... extractor design that is packaged 12 ... to remove skin staples. , ... lower jaws of the extractor under ...
... PROXIMATE RH skin stapler is a ... head assembly., ,PROXIMATE RH has improved ... along with a ratchet mechanism for easier ... a sterile, single patient use instrument designed ...
... use, reloadable articulating (22° and 45° in ... handle for resection, transection and anastomosis for ... stapler places two triple-staggered rows of staples ... in between. The instrument is designed for ...
Medicine Products: